272 related articles for article (PubMed ID: 2919725)
21. [Effectiveness of aminosidine sulphate in severe visceral leishmaniasis, resistant to the treatment with pentavalent antimony].
Castro C; Macêdo V; Silva-Vergara ML; Cuba C; Silveira CA; Carvalho E; Marsden P
Rev Soc Bras Med Trop; 1995; 28(3):273-7. PubMed ID: 7480924
[TBL] [Abstract][Full Text] [Related]
22. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
23. [Visceral leishmaniasis (kala-azar) on Ilha de São Luís, Maranhão. Brazil: its evolution and outlook].
da Silva AR; Viana GM; Varonil C; Pires B; Nascimento Mdo D; Costa JM
Rev Soc Bras Med Trop; 1997; 30(5):359-68. PubMed ID: 9380895
[TBL] [Abstract][Full Text] [Related]
24. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
[No Abstract] [Full Text] [Related]
25. Post-kala-azar dermal leishmaniasis.
Baghestani S; Handjani F; Sodeifi M; Kumar PV
Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
[TBL] [Abstract][Full Text] [Related]
26. Diffuse cutaneous leishmaniasis acquired in Peru.
Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS
Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221
[TBL] [Abstract][Full Text] [Related]
27. AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation.
Datry A; Similowski T; Jais P; Rosenheim M; Katlama C; Maheu E; Kazaz S; Fassin D; Danis M; Gentilini M
Trans R Soc Trop Med Hyg; 1990; 84(2):239-40. PubMed ID: 2389314
[No Abstract] [Full Text] [Related]
28. Kala-azar in Afghanistan.
Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
[TBL] [Abstract][Full Text] [Related]
29. [Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].
Puerto-Alonso JL; Molina-Ruano FJ; Gómez-Soto F; Gómez-Rodríguez F
Med Clin (Barc); 2006 Oct; 127(13):519. PubMed ID: 17043012
[No Abstract] [Full Text] [Related]
30. Chemotherapy of experimental visceral leishmaniasis in the opossum.
White MR; Chapman WL; Hanson WL
J Parasitol; 1989 Feb; 75(1):176-8. PubMed ID: 2918440
[TBL] [Abstract][Full Text] [Related]
31. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
[TBL] [Abstract][Full Text] [Related]
32. [N-methyl glucamine antimoniate or Glucantime].
Rapp C; Simon F; Dordain ML
Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
[No Abstract] [Full Text] [Related]
33. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL
Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727
[TBL] [Abstract][Full Text] [Related]
34. [Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].
Rovira RE; Díaz-Gómez JR; Lapuebla X; Aguar MC
Enferm Infecc Microbiol Clin; 2005 May; 23(5):327. PubMed ID: 15899186
[No Abstract] [Full Text] [Related]
35. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Kuyucu N; Kara C; Bakirtaç A; Teziç T
Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
[TBL] [Abstract][Full Text] [Related]
36. Treatment of kala-azar in India.
Thakur CP
Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
[No Abstract] [Full Text] [Related]
37. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
[No Abstract] [Full Text] [Related]
38. [Visceral kala-azar of Spanish origin. Apropos of a case].
De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
[No Abstract] [Full Text] [Related]
39. Chemotherapy of leishmaniasis in India.
Thakur CP
Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
[No Abstract] [Full Text] [Related]
40. Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.
Fretzayas A; Moustaki M; Kitsiou S; Mathioudakis J; Karpathios T
Scand J Infect Dis; 2001; 33(11):865-7. PubMed ID: 11760174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
